Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Marrone Bio Inks Regalia Maxx Distribution Deal With Disagro

Published 12/20/2017, 08:44 PM
Updated 07/09/2023, 06:31 AM

Marrone Bio Innovations, Inc. (NASDAQ:MBII) has inked an exclusive deal to distribute and market its biofungicide, Regalia Maxx with Disagro, the leading supplier of agricultural inputs in Central America.

Regalia Maxx, which is registered in Belize, Guatemala, Honduras, Nicaragua, El Salvador, Panama and Costa Rica, stimulates the plant’s intrinsic ability to fight diseases and delivers improved harvest quality and better yield. It is used for the control of a wide variety of fungal and bacterial diseases across a range of agricultural crops.

Regalia can offer residue management benefits to many key export crops grown in Central America. Per the Central America Data, exports in the region aggregated $6.75 billion in 2016, including key crops like bananas ($2.39 billion), coffee ($2.38 billion), sugar cane ($1.02 billion) and pineapple ($950 million).

Marrone Bio stated that its unique product Regalia Maxx and Disagro’s focus on operational excellence and technical innovation along with market knowledge will provide the farmers in Central America with effective solutions for yield enhancement and disease control.

Shares of Marrone Bio have declined 11% in the past three months, underperforming the industry’s 5.9% growth.

Marrone Bio, during third-quarter earnings, said that it has made significant progress in penetrating the United States and overseas markets and also remains positive on the long-term outlook of its business. The company also expects its ongoing manufacturing process improvement initiatives in R&D to continue to contribute to an improvement in margins moving ahead.

Zacks Rank & Key Picks

Marrone Bio currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the basic materials space are Westlake Chemical Corporation (NYSE:WLK) , Daqo New Energy Corp. (NYSE:DQ) and Kronos Worldwide Inc. (NYSE:KRO) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Westlake Chemical has an expected long-term earnings growth rate of 10.6%. Its shares have risen 84.9% year to date.

Daqo New Energy has an expected long-term earnings growth rate of 7%. Its shares have surged a whopping 148.8% year to date.

Kronos Worldwide has an expected long-term earnings growth rate of 5%. Its shares have rallied 119.4% year to date.

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.

Click here for Zacks' private trades >>

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

Marrone Bio Innovations, Inc. (MBII): Free Stock Analysis Report

Westlake Chemical Corporation (WLK): Free Stock Analysis Report

DAQO New Energy Corp. (DQ): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.